ABSTRACTS

LATE BREAKING CLINICAL TRIALS

The ERA-EDTA will consider abstracts related to unpublished clinical trials for a special “Late breaking clinical trials” session. The following trials will be considered for evaluation if they comply with the required characteristics:

- a prospective randomised intervention in renal patients (medications, education, dietetics, physiotherapy, etc…), including at least 100 patients;
- a prospective observational study, including at least 500 patients;
- approved by an institutional ethical committee;
- not previously reported or published.

Abstracts may be accepted as oral communications or posters, after regular evaluation by the review committee.
The LBCT abstracts can be submitted from February 22 to March 14, 2016.

Abstracts which do not meet the criteria above will not be considered for presentation.

The Abstract Submission for the 53rd ERA-EDTA Congress closed on January 15, 2016.

 
Communications should concern all aspects of nephrology, the prevention and treatment of renal diseases and associated conditions or the scientific background to the study of the kidney.

GENERAL RULES
The Abstract Submission closed on January 15, 2016.

CONFIRMATION
You will automatically receive an e-mail confirming our receipt of your abstract.

NOTIFICATION
The Presenting Author of each abstract accepted for publication will be notified by March 23, 2016. If the Presenting Author is unable to present the abstract, another co-author can take his/her place. A letter from the Presenting Author about the change is requested and must be received by the ERA-EDTA Congress Office no later than April 10, 2016.

WITHDRAWAL / CHANGES
Submitted abstracts cannot be withdrawn or changed. No exceptions will be made.

ORIGINAL ABSTRACTS
Submitted abstracts must describe unpublished work which is not already in press and which is not awaiting possible acceptance by any other society that publishes its proceedings.

LANGUAGE
All abstracts must be written in English.

HOW TO SUBMIT ABSTRACTS
Only online submission was possible. The Abstract Submission closed on January 15, 2016.
All authors of correctly written and successfully submitted abstracts will receive confirmation by e-mail.

PUBLICATION
All abstracts accepted for presentation (either oral or poster) will appear in NDT. Abstracts will appear exactly as submitted. Any abstract considered unsuitable for reproduction will not be published.


IMPORTANT INFORMATION FOR YOUNG ABSTRACT AUTHORS

ERA-EDTA STANLEY SHALDON AWARD FOR YOUNG INVESTIGATORS
If you are 40 years old or younger, and your abstract is considered one of the best ones submitted to the last three ERA-EDTA Congresses, you can win the ERA-EDTA Stanley Shaldon Award for Young Investigators.
The winner will receive the award during the Opening Ceremony of the annual ERA-EDTA Congress.
The award consists in a special invitation to participate in the ERA-EDTA Congress in which the award is given; three years of ERA-EDTA membership; an ex-officio position in the Young Nephrologists’ Platform Board and a prize of EUR 10,000. Do not miss this unique opportunity to submit your abstract to the ERA-EDTA!
For more information you can go to our website www.eraedta. org (click on “About ERA-EDTA” and then on “ERA-EDTA Awards”).

YOUNG NEPHROLOGISTS’ PLATFORM “FREE MEMBERSHIP PROJECT”
A 1-year free membership will be given, automatically, to the 30 young people who have submitted an accepted abstract to an ERA-EDTA Congress. Only young people (< 40 years of age) who are already ERA-EDTA MEMBERS and YNP MEMBERS can receive this free ERA-EDTA membership. More information will be available during the abstract submission procedure.

ABSTRACT CATEGORIES


Abstract submission deadline: JANUARY 15, 2016, 23.59 CET.

For any information please contact:
ERA-EDTA Congress Office

Phone: